ImmuneOnco Biopharmaceuticals (Shanghai) Inc

01541

Company Profile

  • Business description

    ImmuneOnco Biopharmaceuticals (Shanghai) Inc is a science-driven biotechnology company dedicated to the development of immuno-oncology therapies. It is one of the few biotechnology companies globally adopting a systematic approach to harness both the innate and adaptive immune systems. It has developed a rich pipeline of 14 drug candidates with eight ongoing clinical programs, featured by a comprehensive innate-immunity-based asset portfolio. Its pipeline reflects its extensive understanding of the frontiers of cancer biology and immunology and its expertise in turning scientific research into drug candidates.

  • Contact

    1000 Zhangheng Road
    Unit 15, China (Shanghai) Pilot Free Trade Zone
    Pudong New Area
    Shanghai
    CHN

    T: +86 2138016387

    https://cn.immuneonco.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    31 December 2025

    Employees

    156

Stocks News & Analysis

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,789.4045.800.52%
CAC 407,691.55134.241.78%
DAX 4024,033.22383.921.62%
Dow JONES (US)43,819.27432.431.00%
FTSE 1008,798.9163.310.72%
HKSE24,182.95101.20-0.42%
NASDAQ20,273.46105.550.52%
Nikkei 22540,624.59473.801.18%
NZX 50 Index12,565.1218.47-0.15%
S&P 5006,173.0732.050.52%
S&P/ASX 2008,561.4047.200.55%
SSE Composite Index3,431.186.950.20%

Market Movers